Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
July 25, 2019
Arvinas Strengthens Board of Directors with Addition of Leslie Norwalk
July 19, 2019
Arvinas to Present Preclinical Tau-Directed PROTAC® Protein Degrader Data at Alzheimer’s Association International Conference
July 19, 2019
Pear Therapeutics Announces FDA Submission for SOMRYST™, a Prescription Digital Therapeutic for the Treatment of Adults with Chronic Insomnia and Depression
July 18, 2019
Rallybio Expands Drug Development Team with Addition of Ann Willauer, PMP
July 18, 2019
Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and Head of Clinical Development
July 18, 2019
Autoimmune Clinical Drug Development Expert, David J. Chang, M.D., M.P.H., Joins Cabaletta Bio as Chief Medical Officer
July 16, 2019
Homology Medicines Appoints Alise Reicin, MD, to the Board of Directors
July 12, 2019
IDEAYA Biosciences Announces First Patient Dosing of PKC inhibitor IDE196 in Phase 1/2 Tissue-Type Agnostic Basket Trial for Solid Tumors Harboring GNAQ or GNA11 Mutations
July 12, 2019
Kinestral Technologies’ Halio Cloud Becomes the First Globally Deployed Smart Window Control System
June 25, 2019
Arvinas Receives Authorization to Proceed for ARV-471, a PROTAC® Protein Degrader to Treat Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer
« Previous Page
1
…
5
6
7
8
9
…
12
Next Page »